Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × tipifarnib × 1 year × Clear all

Phase

Status

Active not recruiting 2 Recruiting 1 Completed 1 Available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1

Interventions

Specimen Handling 428 pembrolizumab 422 Magnetic Resonance Spectroscopy 370 Carboplatin 302 Cyclophosphamide 270 Cisplatin 255 Biopsy 237 Radiotherapy 213 Paclitaxel 199 Gemcitabine 199 Bevacizumab 186 Nivolumab 170 venetoclax 166 fludarabine 156 Drug Therapy 145 Blood Specimen Collection 144 Dexamethasone 140 Docetaxel 135 Oxaliplatin 134 Injections 134 Capecitabine 133 Fluorouracil 132 Radiosurgery 122 Rituximab 121 Standard of Care 119 Pemetrexed 114 atezolizumab 105 durvalumab 100 Radiation 100 Doxorubicin 97

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06540963 2026-03-02

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

Milton S. Hershey Medical Center

Phase 2 Recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡